-
NORD share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of NORD shares has decreased $0.04 since the market last closed. This is a 1.08% drop.
-
Closed at $3.21.
The stock has since dropped $0.13 in after-hours trading.
Key terms
About NORD
Nordicus Partners Corp. is a biotech company, which specializes in developing breakthrough therapeutics in diseases with unmet medical needs. It focuses on acquisition and development of drugs from innovative biotech companies in the Nordics. The company was founded on April 7, 1993 and is headquartered in Beverly Hills, CA.
-
Market cap: $62.51M
A market capitalization up to $300 million places NORD in the micro-capitalization category.
Key terms
Smart score
Latest NORD news
No recent press releases are available for NORD
NORD Financials
-
NORD total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$4.00M (1Y), -$2.28M (Q1)
Net Income decreased 37.93% since last year and decreased 3956.71% since last quarter.
-
Earnings per share: -$0.22 (1Y), -$0.12 (Q1)
EPS increased 29.95% since last year and decreased 3996.55% since last quarter.
Key terms
NORD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NORD Competitors
-
How competitors are chosen
NORD's competitors are included in the Process Industries sector and Chemicals: Specialty group
-
Market cap: $62.51M
A market capitalization up to $300 million places NORD in the micro-capitalization category.
